News Headlines Article

Drug Shows Promise in Advanced Prostate Cancer When Used Before Chemotherapy
New York Times

The prostate cancer drug Xtandi prolonged lives and delayed tumor progression when used before chemotherapy in a study of men with advanced cases of the disease, researchers said on Tuesday.

The study results are expected to open up a broader market for Xtandi, which was developed by Medivation and Astellas Pharma, and open a new front in its competition with Johnson & Johnson’s blockbuster drug Zytiga.

Commands